Clinical Trial Update: Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two dosages of nebulized corticosteroid versus parenteral corticosteroid for management of COPD exacerbations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• nebulized corticosteroid
• parenteral corticosteroid

Snippet

Sponsor: Ataturk University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED